BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Nov 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-11-16

Reporting Person: LAWLIS V BRYAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-16	Common Stock	S	1050	$104.2552	Disposed	11850	Direct
2015-11-16	Common Stock	M	7500	$17.33	Acquired	19350	Direct
2015-11-16	Common Stock	S	7500	$107.2707	Acquired	11850	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-16	Stock Option (right to buy) common stock	$17.33	M	7500	Disposed	2017-06-06	Common Stock (7500)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on August 24, 2015.

F2: The price in column 4 is an average weighted price. The price actually received ranged from $103.07 to $106.12. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price in column 4 is a weighted average price. The price actually received ranged from $102.98 to $106.81. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.

F4: Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter.

F5: Reflects the number of stocks options that remain outstanding from this specific stock option grant following the reported transaction.